Document is current
Any future updates will be listed below
-
Authors
Novak, Peter
Witte, Alexandra
Marciano, Sadie P.
Felsenstein, Donna
Ngo, Long
-
Funding
Funding for this research was provided by:
Mona Taliaferro/Bay Shore Recycling
The National Heart, Lung and Blood Institute (1OT2HL156812-01)
FBRI (2022A018462)
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 15 December 2025
First Online: 20 December 2025
Competing interests
: PN is a current or previous shareholder of Moderna, Editas Medicine, Novavax, and Pfizer. PN received royalties from Oxford University Press and he is advisor - independent Contractor for Dysimmune Diseases Foundation. The remaining authors have no conflicts of interest to disclose.
